MCM
PFE icon

Mainstay Capital Management’s Pfizer PFE Stock Holding History

Mainstay Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-38,947
Closed -$1.03M – 115
2024
Q4 		$1.03M Buy
38,947
+7,955
+26% +$216K 0.16% 55
2024
Q3 		$897K Buy
30,992
+2,732
+10% +$79.7K 0.15% 53
2024
Q2 		$791K Buy
28,260
+4,483
+19% +$123K 0.14% 56
2024
Q1 		$660K Sell
23,777
-3,446
-13% -$95.6K 0.12% 62
2023
Q4 		$784K Buy
27,223
+6,223
+30% +$188K 0.15% 56
2023
Q3 		$697K Sell
21,000
-7,172
-25% -$254K 0.15% 55
2023
Q2 		$1.03M Sell
28,172
-300
-1% -$11.7K 0.19% 48
2023
Q1 		$1.16M Sell
28,472
-1,550
-5% -$66.9K 0.23% 43
2022
Q4 		$1.54M Sell
30,022
-1,775
-6% -$85.1K 0.34% 36
2022
Q3 		$1.39M Sell
31,797
-3,162
-9% -$154K 0.35% 32
2022
Q2 		$1.83M Sell
34,959
-55
-0.2% -$2.8K 0.42% 19
2022
Q1 		$1.81M Sell
35,014
-225
-0.6% -$11.7K 0.33% 25
2021
Q4 		$2.08M Sell
35,239
-3,851
-10% -$191K 0.63% 21
2021
Q3 		$1.68M Buy
39,090
+32,697
+511% +$1.45M 0.96% 21
2021
Q2 		$251K Buy
6,393
+51
+0.8% +$1.98K 0.06% 108
2021
Q1 		$230K Sell
6,342
-283
-4% -$10K 0.07% 115
2020
Q4 		$243K Sell
6,625
-59
-0.9% -$2.16K 0.07% 101
2020
Q3 		$233K Buy
+6,684
New +$234K 0.06% 106
2020
Q1 		– Sell
-6,554
Closed -$244K – 104
2019
Q4 		$244K Hold
6,554
– – 0.06% 92
2019
Q3 		$223K Hold
6,554
– – 0.12% 95
2019
Q2 		$270K Buy
6,554
+1,054
+19% +$41.9K 0.14% 84
2019
Q1 		$221K Sell
5,500
-1,581
-22% -$63.3K 0.17% 79
2018
Q4 		$291K Sell
7,081
-527
-7% -$21.9K 0.21% 72
2018
Q3 		$318K Sell
7,608
-1,238
-14% -$47.7K 0.2% 82
2018
Q2 		$304K Buy
8,846
+2,188
+33% +$74.8K 0.24% 73
2018
Q1 		$224K Buy
6,658
+554
+9% +$19K 0.17% 88
2017
Q4 		$210K Buy
+6,104
New +$208K 0.17% 94

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
TIM
Thornburg Investment Management Santa Fe, New Mexico $9.63B AUM 35.65% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Mainstay Capital Management's PFE Position: Q1 2025 in Review

Mainstay Capital Management sold out of Pfizer (PFE) in Q1 2025, closing a stake of 38,947 shares — an estimated $1.03M sold.

Mainstay Capital Management first reported a position in PFE in Q4 2017 and held it in 27 quarters. The position peaked at $2.08M in Q4 2021. 2,930 funds tracked by Wall St. Rank hold PFE as of Q1 2025.

  • Mainstay Capital Management reported no remaining Pfizer position as of Q1 2025 after selling out during the quarter.
  • Mainstay Capital Management sold 38,947 Pfizer shares in Q1 2025, an estimated $1.03M.
  • Mainstay Capital Management first reported a position in Pfizer in Q4 2017 and held it in 27 quarters.
  • Mainstay Capital Management's Pfizer position peaked at $2.08M in Q4 2021.
  • 2,930 funds tracked by Wall St. Rank held Pfizer as of Q1 2025.

Based on Mainstay Capital Management's 13F filing for Q1 2025, filed 5 May 2025.